Nuwellis, Inc. (NASDAQ:NUWE – Get Rating) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 34,900 shares, a growth of 149.3% from the April 30th total of 14,000 shares. Based on an average daily volume of 146,900 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.3% of the company’s shares are sold short.
Shares of NUWE stock opened at $0.57 on Friday. The stock has a market cap of $5.74 million, a PE ratio of -0.25 and a beta of 0.89. The business has a 50-day simple moving average of $0.85 and a 200-day simple moving average of $1.09. Nuwellis has a 52-week low of $0.55 and a 52-week high of $5.39.
Nuwellis (NASDAQ:NUWE – Get Rating) last released its quarterly earnings results on Tuesday, March 1st. The company reported ($0.41) earnings per share for the quarter. The business had revenue of $1.64 million during the quarter. Nuwellis had a negative return on equity of 72.68% and a negative net margin of 237.48%. During the same period last year, the firm earned ($1.13) earnings per share. As a group, research analysts expect that Nuwellis will post -1.47 EPS for the current year.
Separately, Zacks Investment Research upgraded Nuwellis from a “hold” rating to a “buy” rating and set a $0.75 target price on the stock in a research note on Saturday, May 14th.
About Nuwellis (Get Rating)
Nuwellis, Inc, a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.
- Get a free copy of the StockNews.com research report on Nuwellis (NUWE)
- Should Dollar General or Dollar Tree Give Investors a Case of FOMO?
- Genesco Pops On Earnings But Don’t Expect A Rally
- The Insiders Are Selling Movado Group, But You Shouldn’t
- Beware The Rebound In Retail Stocks
- It’s A Good Time To Own Ralph Lauren (NYSE: RL)
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.